The human rhabdomyosarcoma cell line TE671 - Towards an innovative production platform for glycosylated biopharmaceuticals

Protein Expression and Purification

Volumn 115, Issue , 2015, Pages 83-94

  Rosenlöcher, Julia ^a,b   Weilandt, Constanze ^a   Sandig, Grit ^a   Reinke, Stefan O ^a   Blanchard, Véronique ^c   Hinderlich, Stephan ^a  

^a BEUTH UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alpha 1 antitrypsin; Granulocyte?macrophage colony stimulating factor; N glycosylation; TE671; Therapeutic glycoprotein

Indexed keywords

GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN;

BIOTECHNOLOGY; CARBOHYDRATE ANALYSIS; CHEMISTRY; GLYCOSYLATION; HUMAN; METABOLISM; PROCEDURES; TUMOR CELL LINE;

BIOTECHNOLOGY; CARBOHYDRATE SEQUENCE; CELL LINE, TUMOR; GLYCOPROTEINS; GLYCOSYLATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; RECOMBINANT PROTEINS;

EID: 84941933769     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2015.08.008     Document Type: Article

References (58)

1. N. Sethuraman, and T.A. Stadheim Challenges in therapeutic glycoprotein production Curr. Opin. Biotechnol. 17 2006 341 346
2. J. Zhang Mammalian cell culture for biopharmaceutical production R.H. Baltz, A.L. Demain, J.E. Davies, Manual of Industrial Microbiology and Biotechnology 2010 ASM Press Washington, DC 157 178
3. Y. Durocher, and M. Butler Expression systems for therapeutic glycoprotein production Curr. Opin. Biotechnol. 20 2009 700 707
4. M. Butler Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals Appl. Microbiol. Biotechnol. 68 2005 283 291
5. D. Ghaderi, M. Zhang, N. Hurtado-Ziola, and A. Varki Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation Biotechnol. Genet. Eng. Rev. 28 2012 147 175
6. R.L. Shields, J. Lai, R. Keck, L.Y. O'Connell, K. Hong, Y.G. Meng, S.H. Weikert, and L.G. Presta Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity J. Biol. Chem. 277 2002 26733 26740
7. M.N. Fukuda, H. Sasaki, L. Lopez, and M. Fukuda Survival of recombinant erythropoietin in the circulation: the role of carbohydrates Blood 73 1989 84 89
8. P. Weiss, and G. Ashwell The asialoglycoprotein receptor: properties and modulation by ligand Prog. Clin. Biol. Res. 300 1989 169 184
9. J.C. Egrie, E. Dwyer, J.K. Browne, A. Hitz, and M.A. Lykos Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin Exp. Hematol. 31 2003 290 299
10. H.H. Chou, T. Hayakawa, S. Diaz, M. Krings, E. Indriati, M. Leakey, S. Paabo, Y. Satta, N. Takahata, and A. Varki Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution Proc. Natl. Acad. Sci. U.S.A. 99 2002 11736 11741
11. M. Bardor, D.H. Nguyen, S. Diaz, and A. Varki Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells J. Biol. Chem. 280 2005 4228 4237
12. P. Tangvoranuntakul, P. Gagneux, S. Diaz, M. Bardor, N. Varki, A. Varki, and E. Muchmore Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid Proc. Natl. Acad. Sci. U.S.A. 100 2003 12045 12050
13. V. Padler-Karavani, H. Yu, H. Cao, H. Chokhawala, F. Karp, N. Varki, X. Chen, and A. Varki Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease Glycobiology 18 2008 818 830
14. D. Ghaderi, R.E. Taylor, V. Padler-Karavani, S. Diaz, and A. Varki Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins Nat. Biotechnol. 28 2010 863 867
15. U. Galili, F. Anaraki, A. Thall, C. Hill-Black, and M. Radic One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody Blood 82 1993 2485 2493
16. U. Galili The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy Immunol. Cell Biol. 83 2005 674 686
17. G. Schiedner, S. Hertel, C. Bialek, H. Kewes, G. Waschutza, and C. Volpers Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection BMC Biotechnol. 8 2008 13
18. K. Swiech, V. Picanco-Castro, and D.T. Covas Human cells: new platform for recombinant therapeutic protein production Protein Expr. Purif. 84 2012 147 153
19. A. Tchoudakova, F. Hensel, A. Murillo, B. Eng, M. Foley, L. Smith, F. Schoenen, A. Hildebrand, A.R. Kelter, L.L. Ilag, H.P. Vollmers, S. Brandlein, J. McIninch, J. Chon, G. Lee, and M. Cacciuttolo High level expression of functional human IgMs in human PER.C6 cells mAbs 1 2009 163 171
20. D. Jones, N. Kroos, R. Anema, B. Van Montfort, A. Vooys, S.V.D. Kraats, E.V.D. Helm, S. Smits, J. Schouten, K. Brouwer, F. Lagerwerf, P. Van Berkel, D.-J. Opstelten, T. Logtenberg, and A. Bout High-level expression of recombinant IgG in the human cell line PER.C6 Biotechnol. Prog. 19 2003 163 168
21. D. Ross, T. Brown, R. Harper, M. Pamarthi, J. Nixon, J. Bromirski, C.M. Li, R. Ghali, H. Xie, G. Medvedeff, H. Li, P. Scuderi, V. Arora, J. Hunt, and T. Barnett Production and characterization of a novel human recombinant alpha-1-antitrypsin in PER.C6 cells J. Biotechnol. 162 2012 262 273
22. L.T. May, J.E. Shaw, A.K. Khanna, J.B. Zabriskie, and P.B. Sehgal Marked cell-type-specific differences in glycosylation of human interleukin-6 Cytokine 3 1991 204 211
23. R.B. Parekh, R.A. Dwek, J.R. Thomas, G. Opdenakker, T.W. Rademacher, A.J. Wittwer, S.C. Howard, R. Nelson, N.R. Siegel, M.G. Jennings, and et al. Cell-type-specific and site-specific N-glycosylation of type I and type II human tissue plasminogen activator Biochemistry 28 1989 7644 7662
24. S.O. Reinke, M. Bayer, M. Berger, S. Hinderlich, and V. Blanchard The analysis of N-glycans of cell membrane proteins from human hematopoietic cell lines reveals distinctions in their pattern Biol. Chem. 393 2012 731 747
25. R.M. McAllister, H. Isaacs, R. Rongey, M. Peer, W. Au, S.W. Soukup, and M.B. Gardner Establishment of a human medulloblastoma cell line Int. J. Cancer 20 1977 206 212
26. H.S. Friedman, S.C. Schold Jr., and D.D. Bigner Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice Cancer Res. 46 1986 224 228
27. R. Schoepfer, M. Luther, and J. Lindstrom The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor. Cloning of the alpha-subunit cDNA FEBS Lett. 226 1988 235 240
28. M.R. Stratton, J. Darling, G.J. Pilkington, P.L. Lantos, B.R. Reeves, and C.S. Cooper Characterization of the human cell line TE671 Carcinogenesis 10 1989 899 905
29. J. Parada-Turska, R. Paduch, M. Majdan, M. Kandefer-Szerszen, and W. Rzeski Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells Pharmacol. Rep. 59 2007 233 237
30. T.R. Miller, R.D. Taber, E.J. Molinari, K.L. Whiteaker, L.M. Monteggia, V.E. Scott, J.D. Brioni, J.P. Sullivan, and M. Gopalakrishnan Pharmacological and molecular characterization of ATP-sensitive K+ channels in the TE671 human medulloblastoma cell line Eur. J. Pharmacol. 370 1999 179 185
31. C.N. Liu, and C.J. Somps Telithromycin blocks neuromuscular transmission and inhibits nAChR currents in vitro Toxicol. Lett. 194 2010 66 69
32. R.W. Carrell, J.O. Jeppsson, L. Vaughan, S.O. Brennan, M.C. Owen, and D.R. Boswell Human alpha 1-antitrypsin: carbohydrate attachment and sequence homology FEBS Lett. 135 1981 301 303
33. M. Mohanka, D. Khemasuwan, and J.K. Stoller A review of augmentation therapy for alpha-1 antitrypsin deficiency Expert Opin. Biol. Ther. 12 2012 685 700
34. K.S. Kwon, M. Song, and M.H. Yu Purification and characterization of alpha 1-antitrypsin secreted by recombinant yeast Saccharomyces diastaticus J. Biotechnol. 42 1995 191 195
35. A. Castilho, M. Windwarder, P. Gattinger, L. Mach, R. Strasser, F. Altmann, and H. Steinkellner Proteolytic and N-glycan processing of human alpha1-antitrypsin expressed in Nicotiana benthamiana Plant Physiol. 166 2014 1839 1851
36. G.D. Chang, C.J. Chen, C.Y. Lin, H.C. Chen, and H. Chen Improvement of glycosylation in insect cells with mammalian glycosyltransferases J. Biotechnol. 102 2003 61 71
37. E. Karnaukhova, Y. Ophir, and B. Golding Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use Amino Acids 30 2006 317 332
38. D. Metcalf, A.W. Burgess, G.R. Johnson, N.A. Nicola, E.C. Nice, J. DeLamarter, D.R. Thatcher, and J.J. Mermod In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF J. Cell. Physiol. 128 1986 421 431
39. P.P. Jacobs, M. Inan, N. Festjens, J. Haustraete, A. Van Hecke, R. Contreras, M.M. Meagher, and N. Callewaert Fed-batch fermentation of GM-CSF-producing glycoengineered Pichia pastoris under controlled specific growth rate Microb. Cell Fact. 9 2010 93
40. M.A. Cantrell, D. Anderson, D.P. Cerretti, V. Price, K. McKereghan, R.J. Tushinski, D.Y. Mochizuki, A. Larsen, K. Grabstein, S. Gillis, and et al. Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor Proc. Natl. Acad. Sci. U.S.A. 82 1985 6250 6254
41. A.W. Burgess, C.G. Begley, G.R. Johnson, A.F. Lopez, D.J. Williamson, J.J. Mermod, R.J. Simpson, A. Schmitz, and J.F. DeLamarter Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor Blood 69 1987 43 51
42. T. Lieke, D. Grobe, V. Blanchard, D. Grunow, R. Tauber, M. Zimmermann-Kordmann, T. Jacobs, and W. Reutter Invasion of Trypanosoma cruzi into host cells is impaired by N-propionylmannosamine and other N-acylmannosamines Glycoconj. J. 28 2011 31 37
43. S.O. Reinke, M. Bayer, M. Berger, V. Blanchard, and S. Hinderlich Analysis of cell surface N-glycosylation of the human embryonic kidney 293T cell line J. Carbohydr. Chem. 30 2011 218 232
44. Y. Wada, P. Azadi, C.E. Costello, A. Dell, R.A. Dwek, H. Geyer, R. Geyer, K. Kakehi, N.G. Karlsson, K. Kato, N. Kawasaki, K.H. Khoo, S. Kim, A. Kondo, E. Lattova, Y. Mechref, E. Miyoshi, K. Nakamura, H. Narimatsu, M.V. Novotny, N.H. Packer, H. Perreault, J. Peter-Katalinic, G. Pohlentz, V.N. Reinhold, P.M. Rudd, A. Suzuki, and N. Taniguchi Comparison of the methods for profiling glycoprotein glycans - HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study Glycobiology 17 2007 411 422
45. A. Dell, K.-H. Khoo, M. Panico, R.A. McDowell, A.T. Etienne, A.J. Reason, and H.R. Morris M. Fukuda, A. Kobata, Glycobiology: A Practical Approach 1993 IRL Press at Oxford University Press Oxford 187 222
46. E. Frisch, M. Kaup, K. Egerer, A. Weimann, R. Tauber, M. Berger, and V. Blanchard Profiling of Endo H-released serum N-glycans using CE-LIF and MALDI-TOF-MS-application to rheumatoid arthritis Electrophoresis 32 2011 3510 3515
47. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, J.D. Marth, C.R. Bertozzi, G.W. Hart, and M.E. Etzler Symbol nomenclature for glycan representation Proteomics 9 2009 5398 5399
48. A. Lusch, M. Kaup, U. Marx, R. Tauber, V. Blanchard, and M. Berger Development and analysis of alpha 1-antitrypsin neoglycoproteins: the impact of additional N-glycosylation sites on serum half-life Mol. Pharm. 10 2013 2616 2629
49. J. Cao, C. Shen, H. Wang, H. Shen, Y. Chen, A. Nie, G. Yan, H. Lu, Y. Liu, and P. Yang Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach J. Proteome Res. 8 2009 662 672
50. M. Devasahayam Factors affecting the expression of recombinant glycoproteins Indian J. Med. Res. 126 2007 22 27
51. V. Blanchard, X. Liu, S. Eigel, M. Kaup, S. Rieck, S. Janciauskiene, V. Sandig, U. Marx, P. Walden, R. Tauber, and M. Berger N-glycosylation and biological activity of recombinant human alpha1-antitrypsin expressed in a novel human neuronal cell line Biotechnol. Bioeng. 108 2011 2118 2128
52. Z. Wang, T.L. Hilder, K. van der Drift, J. Sloan, and K. Wee Structural characterization of recombinant alpha-1-antitrypsin expressed in a human cell line Anal. Biochem. 437 2013 20 28
53. T.P. Patel, R.B. Parekh, B.J. Moellering, and C.P. Prior Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody Biochem. J. 285 1992 839 845
54. F. Le Floch, B. Tessier, S. Chenuet, J.M. Guillaume, P. Cans, A. Marc, and J.L. Goergen HPCE monitoring of the N-glycosylation pattern and sialylation of murine erythropoietin produced by CHO cells in batch processes Biotechnol. Prog. 20 2004 864 871
55. M. Gawlitzek, U. Valley, M. Nimtz, R. Wagner, and H.S. Conradt Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions J. Biotechnol. 42 1995 117 131
56. G. Walsh Biopharmaceutical benchmarks 2006 Nat. Biotechnol. 24 2006 769 776
57. P. Hossler, S.F. Khattak, and Z.J. Li Optimal and consistent protein glycosylation in mammalian cell culture Glycobiology 19 2009 936 949
58. G. Negroiu, N. Branza-Nichita, A.J. Petrescu, R.A. Dwek, and S.M. Petrescu Protein specific N-glycosylation of tyrosinase and tyrosinase-related protein-1 in B16 mouse melanoma cells Biochem. J. 344 1999 659 665